Phase I dose escalation study of the anti-CD2 monoclonal antibody, siplizumab, with DA-EPOCH-R in aggressive peripheral T-cell lymphomas. Issue 6 (3rd June 2018)

Record Type:
Journal Article
Title:
Phase I dose escalation study of the anti-CD2 monoclonal antibody, siplizumab, with DA-EPOCH-R in aggressive peripheral T-cell lymphomas. Issue 6 (3rd June 2018)
Main Title:
Phase I dose escalation study of the anti-CD2 monoclonal antibody, siplizumab, with DA-EPOCH-R in aggressive peripheral T-cell lymphomas
Authors:
Roswarski, Joseph
Roschewski, Mark
Lucas, Andrea
Melani, Christopher
Pittaluga, Stefania
Jaffe, Elaine S.
Steinberg, Seth M.
Waldmann, Thomas A.
Wilson, Wyndham H.
Abstract:
Is Part Of:
Leukemia & lymphoma. Volume 59:Issue 6(2018)
Journal:
Leukemia & lymphoma
Issue:
Volume 59:Issue 6(2018)
Issue Display:
Volume 59, Issue 6 (2018)
Year:
2018
Volume:
59
Issue:
6
Issue Sort Value:
2018-0059-0006-0000
Page Start:
1466
Page End:
1469
Publication Date:
2018-06-03
Subjects:
Leukemia -- Periodicals
Lymphomas -- Periodicals
616.99419
Journal URLs:
http://informahealthcare.com ↗
DOI:
10.1080/10428194.2017.1387908 ↗
Languages:
English
ISSNs:
1042-8194
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 5185.251500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:
6650.xml